Literature DB >> 4552913

5-(1-Adamantyl) pyrimidines as inhibitors of folate metabolism.

Y K Ho, M T Hakala, S F Zakrzewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4552913

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  The effects of boron containing peptides on L1210 lymphoid leukemia metabolism.

Authors:  I H Hall; E S Hall; M C Miller; A Sood; B F Spielvogel
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

2.  Phase I clinical trial and human pharmacokinetics of 2,4-diamino-5-adamantyl-6-methyl pyrimidine ethane sulfonate (DAMP-ES): a lipid-soluble antifolate.

Authors:  P J Creaven; S F Zakrzewski; W R Greco; S Madajewicz; A Mittelman; J E Pontes; C Karakousis; H Takita; A Proefrock
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Cytotoxicity of boron containing dipeptide analogs.

Authors:  S Karthikeyan; A Sood; J Tomasz; B F Spielvogel; I H Hall
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

4.  cis-Bis[(1-adamantylmeth-yl)amine-κN]-dichloridoplatinum(II) N,N-dimethyl-formamide solvate.

Authors:  Fernande D Rochon; Christian Tessier
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.